Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Immunocan logo

Immunocan

Recent Finacing

Series A

Recent Raise

$36.7M

Immunocan develops antibody discovery platforms based on gene-editing technologies.

Shanghai, China
51-100
Private
immunocan.com
PitchBook

Highlights

Focus Areas

Biotechnology
Pharmaceutical
Product Research
Therapeutics

Recent Investors

Vivo Capital logo
G
K
泰煜投资 logo

Financials

$36.7M

Total Raised

1

Funding round

4

Investors


Team

Upgrade to view the team

See the team members at Immunocan.